 |
|
|
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
Contract Number 290-02-0024, Task Order Number 2
Prepared by:
Oregon Evidence-based Practice Center
Center for Health Research, Kaiser Permanente Northwest
3800 North Interstate Avenue
Portland, Oregon 97227
Investigators:
Teresa A. Hillier, MD, MS
Kim K. Vesco, MD, MPH
Evelyn P. Whitlock, MD, MPH
David J. Pettitt, MD (consultant)
Kathy L. Pedula, MS
Tracy L. Beil, MS
AHRQ Publication No. 08-05115-EF-1
May 2008
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0024). The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
Suggested citation: Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T. Screening for Gestational Diabetes Mellitus. Evidence Synthesis No. 60. AHRQ Publication No. 08-05115-EF-1. Rockville, Maryland: Agency for Healthcare Research and Quality. May 2008.
No investigators have any affiliations or financial involvement (e.g., employment, consultancies, honoraria, stock options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in this report.
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
Contract Number 290-02-0024, Task Order Number 2
Prepared by:
Oregon Evidence-based Practice Center
Center for Health Research, Kaiser Permanente Northwest
3800 North Interstate Avenue
Portland, Oregon 97227
Investigators:
Teresa A. Hillier, MD, MS
Kim K. Vesco, MD, MPH
Evelyn P. Whitlock, MD, MPH
David J. Pettitt, MD (consultant)
Kathy L. Pedula, MS
Tracy L. Beil, MS
AHRQ Publication No. 08-05115-EF-1
May 2008
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0024). The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
Suggested citation: Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T. Screening for Gestational Diabetes Mellitus. Evidence Synthesis No. 60. AHRQ Publication No. 08-05115-EF-1. Rockville, Maryland: Agency for Healthcare Research and Quality. May 2008.
No investigators have any affiliations or financial involvement (e.g., employment, consultancies, honoraria, stock options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in this report.
